Ramat-Gan
Israel
46
2024-08-15
The entities that hold a legal rights for patent applications filed by inventor Harats Dror:
Dror Harats from Ramat-Gan, IL has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOSITION COMPRISING AN RNA THERAPEUTIC TARGETING FAT10 AND USES OF SAME FOR TREATING DISORDERS CHARACTERIZED BY ABNORMAL LIPID ACCUMULATION
#2 | 2022-06-09DUNALIELLA ALGA PREPARATION FOR PREVENTION AND/OR TREATMENT OF A NEURODEGENERATIVE DISEASE, A DISORDER ASSOCIATED WITH PROTEIN MISFOLDING AND COGNITIVE DECLINE
#3 | 2021-03-11METHODS AND COMPOSITIONS FOR TUMOR RADIOSENSITIZATION
#4 | 2018-01-18METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#5 | 2018-01-18METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#6 | 2017-01-12METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#7 | 2016-09-29INTERLEUKIN-1 (IL-1) INHIBITORS FOR TREATING FERTILITY DISORDERS
#8 | 2014-06-05PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS
#9 | 2014-01-23Method of treating retinitis pigmentosa
#10 | 2013-11-07Promoters exhibiting endothelial cell specificity and methods of using same
#11 | 2013-10-17Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
#12 | 2013-01-10Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#13 | 2012-12-27Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#14 | 2012-10-04Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects
#15 | 2012-09-20Method for treating psoriasis
#16 | 2012-08-09Promoters exhibiting endothelial cell specificity and methods of using same
#17 | 2011-10-13Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#18 | 2011-08-25PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS
#19 | 2011-08-18PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME
#20 | 2011-08-04Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#21 | 2011-06-02Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#22 | 2011-04-28Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#23 | 2011-02-24Methods of treating ophthalmic disorders
#24 | 2010-11-11Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
#25 | 2010-09-02Therapeutic uses of powder
#26 | 2010-04-01Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#27 | 2010-02-25Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#28 | 2009-12-31Promoters exhibiting endothelial cell specificity and methods of using same
#29 | 2009-09-08Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#30 | 2009-08-20Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#31 | 2008-12-11Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#32 | 2008-10-23Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#33 | 2008-01-24Therapeutic uses of powder
#34 | 2007-12-13Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#35 | 2007-10-09Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
#36 | 2007-05-03Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#37 | 2007-03-06Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#38 | 2006-09-14Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#39 | 2006-06-27Promoters exhibiting endothelial cell specificity and methods of using same
#40 | 2005-12-08Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#41 | 2005-09-08Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
#42 | 2005-08-25Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#43 | 2005-07-07Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of atherosclerosis
#44 | 2005-05-26Promoters exhibiting endothelial cell specificity and methods of using same
#45 | 2005-03-24Therapeutic uses of powder
#46 | 2005-01-04Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
26925 ⎘